Potential overuse of screening mammography and its association with access to primary care

Medical Care

Volumn 52, Issue 6, 2014, Pages 490-495

  Tan, Alai ^a   Kuo, Yong Fang ^a   Goodwin, James S ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Access to care; elderly; medicare; overuse; screening mammography

Indexed keywords

AGED; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER DIAGNOSIS; CANCER SCREENING; CANCER THERAPY; FEMALE; GENERAL PRACTITIONER; HEALTH CARE ACCESS; HEALTH MAINTENANCE ORGANIZATION; HUMAN; ICD-9; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

AGED; EARLY DETECTION OF CANCER; FEMALE; GENERAL PRACTICE; HEALTH RESOURCES; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES MISUSE; HUMANS; LIFE EXPECTANCY; MAMMOGRAPHY; MEDICARE; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; UNITED STATES;

EID: 84901283835     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0000000000000115     Document Type: Article

References (42)

1. Randolph WM, Goodwin JS, Mahnken JD, et al. Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis. Ann Intern Med. 2002;137:783-790.
2. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med. 2009;151:727-737. W237-742.
3. Paci E, Miccinesi G, Pu liti D, et al. Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy. Breast Cancer Res. 2006;8:R68.
4. Nyström L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909-919.
5. Lee SJ, Boscardin WJ, Stijacic-Cenzer I, et al. Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ. 2013;346:e8441.
6. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998-2005.
7. Jørge nsen KJ. Overdiagnosis of invasive breast cancer due to mammography screening. Ann Intern Med. 2012;157:219-220; author reply 221-212.
8. Woloshin S, Schwartz LM. The benefits and harms of mammography screening: understanding the trade-offs. JAMA. 2010;303:164-165.
9. Mehta KM, Fung KZ, Kistler CE, et al. Impact of cognitive impairment on screening mammography use in older US women. Am J Public Health. 2010;100:1917 -1923.
10. Walter LC, Covinsky KE. Cancer screening in elderly patients: A framework for individualized decision making. JAMA. 2001;285:2750-2756.
11. Welch HG. Screening mammography-A long run for a short slide N Engl J Med. 2010;363:1276-1278.
12. Tan A, Kuo YF, Elting LS, et al. Refining physician quality indicator s for screening mammography in older women: distinguishing appropriate use from overuse. J Am Geriatr Soc. 2013;61:380-387.
13. Tan A, Kuo YF, Goodwin JS. Predicting life expectancy for communitydwelling older adults from Medicare claims data. Am J Epidemiol. 2013;178:974-983.
14. Freeman JL, Goodwin JS, Zhang D, et al. Measuring the performance of screening mammography in community practice with Medicare claims data. Women Health. 2003;37:1-15.
15. Randolph WM Mahnken JD Goodwin JS et al Using Medicare data to estimate the prevalence of breast cancer screening in older women: comparison of d ifferent methods to identify screening mammograms Health Serv Res 2002 37 1643-1657
16. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130-1139.
17. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27.
18. Finison KS, Wellins CA, Wennberg DE, et al. Screening mammography rates by specialty of the usual care physician. Eff Clin Pract. 1999; 2:120-125.
19. Shah BR, Hux JE, Laupacis A, et al. Administrative data algorithms can describe ambulatory physician utilization. Health Serv Res. 2007;42: 1783-1796.
20. The Food and Drug A dministration. The Mammography Facility Database. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMQSA/mqsa.cfm. Accessed May 1, 2013.
21. Dartmouth Atlas of Health Care. Selected hospital and physician capacity measures, and claims-based reimbursement measures. Available at: http://www.dartmouthatlas.org/tools/downloads.aspx#resources. Accessed May 1, 2013.
22. Wagner EH. Chronic disease manage ment: what will it take to improve care for chronic illness Eff Clin Pract. 1998;1:2-4.
23. Robert Wood Johnson Foundation and the University ofWisconsin School of Medicine and Public Health. County Health Rankings & Roadmaps. Available at: http://www.countyhealthrankings.org/roadmaps. Accessed March 20, 2013.
24. Walter LC, Eng C, Covinsky KE. Screening mammography for frail older women: what are the burdens J Gen Intern Med. 2001;16: 779-784.
25. Smith RA, Brooks D, Cokkinides V, et al. Cancer screening in the United States, 2013: A review of current American Cancer Society guidelines, cur rent issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin. 2013;63:88-105.
26. Carter HB, Albertsen PC, Barry MJ, et al. Early Detection of Prostate Cancer: AUA guideline. Linthicum, MD: Amercian Urology Association; 2013.
27. Smith AK, Williams BA, Lo B. Discussing overall prognosis with the very elderly. N Engl J Med. 2011;365:2149-2151.
28. Gill T. The central role of prognosis in clinical decision making. JAMA. 2012;307:199-200.
29. Hersch J, Jansen J, Barratt A, et al. Women's views on overdiagnosis in breast cancer screening: A qualitative study. BMJ. 2013;346:f158.
30. Torke AM, Schwartz PH, Holtz LR, et al. Older adults and forgoing cancer screening: " i think it would be strange" . JAMA Intern Med. 2013; 173:526-531.
31. Schwa rtz LM, Woloshin S, Fowler FJ, et al. Enthusiasm for cancer screening in the United States. JAMA. 2004;291:71-78.
32. Rosenbaum L. The whole ball game-overcoming the blind spots in health care reform. N Engl J Med. 2013;368:959-962.
33. Koya DL, Chen JG, Smith TG, et al. Screening mammography use in Medicare beneficiaries reflects 4-year mortality risk. Am J Med. 2011; 124:369.e1-369.e8.
34. Schonberg MA, Bres lau ES, McCarthy EP. Targeting of mammography screening according to life expectancy in women aged 75 and older. J Am Geriatr Soc. 2013;61:388-395.
35. Keyhani S, Falk R, Howell EA, et al. Overuse and systems of care: A systematic review. Med Care. 2013;51:503-508.
36. Mittal S, Lin YL, Tan A, et al. Limited life expectancy among a subgroup of Medicare beneficiaries receiving screening colonoscopies. Clin Gastroenterol Hepatol. 2014;12:443-450.
37. Walter LC Bertenthal D Lindquist K et al PSA screening among elderly men with limited life expectancies JAMA 2006 296 2336-2342.
38. Sima CS, Panageas KS, Schrag D. Cancer screening among patients with advanced cancer. JAMA. 2010;304:1584-1591.
39. Walter LC, Lin dquist K, O'Hare AM, et al. Targeting screening mammography according to life expectancy among women undergoing dialysis. Arch Intern Med. 2006;166:1203-1208.
40. Tan A, Kuo YF, Goodwin JS. Integrating age and comorbidity to assess screening mammography utilization. Am J Prev Med. 2012;42:229-234.
41. Lee SJ, Walter LC. Quality indicators for older adults: preventing unintended harms. JAMA. 2011;306:1481-1482.
42. Walter LC. What is the right cancer screening rate for older adults: comment on " prevalence of cancer screening in older, racially diverse adults" . Arch Intern Med. 2011;171:2037-2038.